KD Hospital COO Dr Parth Desai, Amneal Healthcare’s Managing Director & President, India Business and Emerging Markets Shyamakant Giri, Dr Harjeet Dumra, Dr Jigar Mehta and their colleagues share insights on AMR and the latest innovation in IV infusion in Ahmedabad
WHO World Health Organization warned that antimicrobial resistance is one of the top ten global public health threats facing humanity
India is one of the countries worst hit by what doctors call “antimicrobial resistance” (AMR) – antibiotic-resistant. The World Health Organization (WHO) warned that antimicrobial resistance is one of the top ten global public health threats facing humanity. Experts have even estimated that as many as ten million people could die each year as a result of antimicrobial resistance by 2050.
Antibiotics – which are considered to be the first line of defence against severe infections – did not work on most of these cases.
To mark the International Infection Pr
World Infection Prevention Week – October 16-22 – KD Hospital, Ahmedabad on Tuesday announced that it is one of the leading institutes focusing its efforts to create awareness around the increasing trend and effective management of antimicrobial resistance (AMR).
“Antimicrobial resistance (AMR) is already quietly killing an estimated 7,00,000 people each year. This unfortunate reality is not making headlines. We need to prioritize AMR as the threat that it is and understand and communicate the consequences if it continues to go unchecked. The COVID-19 pandemic has shown how infectious diseases can travel the globe and affect nearly every aspect of our daily lives. It also provides a window into our future if we do not mobilize a coordinated, sufficient national response to drug-resistant infections caused by antimicrobial resistance (AMR)” commented, Dr Parth Desai, Chief Operating Officer, KD Hospital.
As part of its awareness campaign, the hospital will undertake various initiatives in sync with other hospitals, healthcare workers, including medical practitioners in rural areas. And for the first time, we are carrying out this awareness drive against this. We urge the common public, not to take self-medication of taking anti-biotics and visit the hospitals to prevent the spraed of AMR, added Dr Parth Desai.
Dr Harjeet Dumra, Senior Pulmonologist and Intensivist said, “Adopting antimicrobial stewardship is a critical component of this, and one of the first steps that must be taken is to raise awareness and understanding of AMR through effective communication. The Centre has taken cognisance of this and set up a high-powered panel to suggest various measures to contain it.”
Dr Jigar Mehta, Intensivist emphasized Governments, researchers, and industry partners around the world have mobilized to develop recommendations, diagnostics, therapeutics, and vaccines for COVID-19. It’s important to mobilize now to address AMR in the same way Shyamakant Giri, Managing Director & President, India Business and Emerging Markets, Amneal Healthcare said As industry patrons, it is also our responsibility to develop or collaborate in developing platforms which help in preventing transmission of hospital infections and antimicrobial drug resistance. Uniport is a first-of-its-kind closed IV technology platform that is being manufactured by Amneal for India, in India. This will set new standards for delivery of IV solutions in the country.
